MEDNAX (MD) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MEDNAX Reports Double-Digit Fourth Quarter 2015 Revenue and EPS Growth
February 4, 2016 6:00 AM ESTReports Fourth-Quarter Adjusted EPS of $1.13
Expects First Quarter 2016 Adjusted EPS of $0.85 to $0.89
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal and other pediatric services, anesthesia, maternal-fetal, radiology, pediatric cardiology and other physician and management services, today reported earnings of $0.99 per diluted share for the three months ended December 31, 2015, an increase of 11 percent over the prior-year period. On a non-GAAP basis, MEDNAX reported Adjusted EPS of $1.13, an increase of 13 percent over the prior-year period.
For the 2015 fourth quarter... More
